Biomerica Announces Direct-to-Consumer Availability of inFoods® IBS Test, Targeting Relief for Bloating and Gastrointestinal Pain

Core Insights - Biomerica, Inc. has enhanced its inFoods® IBS platform, allowing US consumers to order the inFoods® IBS test online and collect samples at home with physician oversight [1][2][6] - The inFoods® IBS test offers a personalized, non-invasive solution for managing Irritable Bowel Syndrome (IBS) symptoms by identifying specific food triggers [2][3] - A recent clinical study showed that the inFoods® IBS test significantly improved key IBS symptoms, such as Abdominal Pain Intensity (API) and bloating, without the side effects associated with traditional drug therapies [4][8] Company Overview - Biomerica, Inc. is a global biomedical technology company focused on developing advanced diagnostic and therapeutic products for medical conditions, particularly gastrointestinal and inflammatory diseases [7] - The company aims to enhance health and well-being while reducing healthcare costs through its innovative products [7] Industry Context - IBS affects approximately 1 in 20 Americans, leading to an estimated $10 billion in annual direct medical costs, highlighting the economic burden of the condition [5] - The complexity of IBS often leaves patients struggling to find effective treatments, creating a significant market opportunity for personalized solutions like the inFoods® IBS test [5][6]